Impacting Pancreatic Cancer Therapy in Heterotypic in Vitro Organoids and in Vivo Tumors with Specificity-Tuned, NIR-Activable Photoimmunonanoconjugates: Towards Conquering Desmoplasia?

Despite untiring efforts to develop therapies for pancreatic ductal adenocarcinoma (PDAC), survival statistics remain dismal, necessitating distinct approaches. Photodynamic priming (PDP), which improves drug delivery and combination regimens, as well as tumor photodestruction are key attributes of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Nano Lett
Autors principals: Obaid, Girgis, Bano, Shazia, Mallidi, Srivalleesha, Broekgaarden, Mans, Kuriakose, Jerrin, Silber, Zachary, Bulin, Anne-Laure, Wang, Yucheng, Mai, Zhiming, Jin, Wendong, Simeone, Diane, Hasan, Tayyaba
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6934365/
https://ncbi.nlm.nih.gov/pubmed/31518145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.nanolett.9b00859
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars